Singapore, 30 November 2011 ‐ Biosensors International Group, Ltd. (“Biosensors”, “Company”, Bloomberg: BIG SP) today announced Wellford Capital Limited, a wholly‐owned subsidiary of Weigao International Medical Co. Limited, which is in turn a wholly‐owned subsidiary of Shandong Weigao Group Medical Polymer Company Limited (“Shandong Weigao”) has fully exercised its rights in converting the US$120 million principal amount of 4% convertible notes due 2014 held in Biosensors.
As a result, Shandong Weigao will become the single largest shareholder of Biosensors with 370 million shares, or approximately 21.6% of the Company.
due 2014. Why convert so early?
Still Can Short Kep Corp? - Siew Mun29 May 2020 at 15:19:00 GMT+8 Make sense to buy now since Temasek offer at 7.35? ReplyDelete Probably still can short Kep Corp as Temasek’s offer m...
53 minutes ago